TRUNCATED IL-17RA SOLUBLE RECEPTOR AND METHODS OF USING IN INFLAMMATION
    20.
    发明申请
    TRUNCATED IL-17RA SOLUBLE RECEPTOR AND METHODS OF USING IN INFLAMMATION 审中-公开
    交联的IL-17RA可溶性受体及其在炎症中的使用方法

    公开(公告)号:US20070197441A1

    公开(公告)日:2007-08-23

    申请号:US11673914

    申请日:2007-02-12

    IPC分类号: A61K38/17 C07K14/715

    摘要: The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17A alone, or both IL-17A and IL-17F polypeptide molecules. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. IL-17RA is a receptor for IL-17A and does also bind IL-17F. The present invention includes a truncated soluble IL-17RA, as well as methods for antagonizing IL-17A or both IL-17A and IL-17F using such a truncated soluble receptor.

    摘要翻译: 本发明涉及阻断,抑制,降低,拮抗或中和IL-17A单独或IL-17A和IL-17F多肽分子的活性。 IL-17A和IL-17F是参与炎症过程和人类疾病的细胞因子。 IL-17RA是IL-17A的受体,并且还结合IL-17F。 本发明包括截短的可溶性IL-17RA,以及使用这种截短的可溶性受体拮抗IL-17A或IL-17A和IL-17F两者的方法。